Gene · 1457
Papers3,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human O-GlcNAcase Uses a Preactivated Boat-skew Substrate Conformation for Catalysis. Evidence from X-ray Crystallography and QM/MM Metadynamics. | ACS Catal | 2023 | 37969138 | PubTator, text mining | PubMed |
| RNA isoform expression landscape of the human dorsal root ganglion (DRG) generated from long read sequencing. | bioRxiv | 2023 | 37961262 | PubTator, text mining | PubMed |
| Erratum: CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression. | Hepatol Commun | 2023 | 37930148 | PubTator, text mining | PubMed |
| Rational therapeutic targets with biomolecular liquid-liquid phase separation regulating synergy: A pan-cancer analysis. | PLoS One | 2023 | 37917664 | PubTator, text mining | PubMed |
| Exosomal Circular Ribonucleic Acid-Microribonucleic Acid Expression Profile from Plasma in Alzheimer's Disease Patients by Bioinformatics and Integrative Analysis. | Eurasian J Med | 2023 | 37909192 | PubTator, text mining | PubMed |
| Optimization of 3-Cyano-7-cyclopropylamino-pyrazolo[1,5-a]pyrimidines toward the Development of an In Vivo Chemical Probe for CSNK2A. | ACS Omega | 2023 | 37901516 | PubTator, text mining | PubMed |
| Phosphorylated HP1α-Nucleosome Interactions in Phase Separated Environments. | J Am Chem Soc | 2023 | 37870432 | PubTator, text mining | PubMed |
| Inhibition of CK2/ING4 Pathway Facilitates Non-Small Cell Lung Cancer Immunotherapy. | Adv Sci (Weinh) | 2023 | 37870169 | PubTator, text mining | PubMed |
| Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy. | Mol Cell Proteomics | 2023 | 37852321 | PubTator, text mining | PubMed |
| TWN-FS method: A novel fragment screening method for drug discovery. | Comput Struct Biotechnol J | 2023 | 37841326 | PubTator, text mining | PubMed |
| Integrated analysis of EGFR mutated non-small cell lung cancer reveals two distinct molecular subtypes. | Clin Transl Med | 2023 | 37830123 | PubTator, text mining | PubMed |
| Advanced stage, high-grade primary tumor ovarian cancer: a multi-omics dissection and biomarker prediction process. | Sci Rep | 2023 | 37828118 | PubTator, text mining | PubMed |
| Genes encoding teleost orthologues of human signal transduction proteins remain duplicated or triplicated more frequently than the whole genome. | Heliyon | 2023 | 37809565 | PubTator, text mining | PubMed |
| On the regulation of human D-aspartate oxidase. | Protein Sci | 2023 | 37805834 | PubTator, text mining | PubMed |
| Cell-specific secretory granule sorting mechanisms: the role of MAGEL2 and retromer in hypothalamic regulated secretion. | Front Cell Dev Biol | 2023 | 37799273 | PubTator, text mining | PubMed |
| Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor Progression. | Int J Mol Sci | 2023 | 37762212 | PubTator, text mining | PubMed |
| Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines. | Biomedicines | 2023 | 37760847 | PubTator, text mining | PubMed |
| Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques. | Cancers (Basel) | 2023 | 37760539 | PubTator, text mining | PubMed |
| In Vitro and In Silico Investigation of BCI Anticancer Properties and Its Potential for Chemotherapy-Combined Treatments. | Cancers (Basel) | 2023 | 37760412 | PubTator, text mining | PubMed |
| WNT pathway in focal cortical dysplasia compared to perilesional nonlesional tissue in refractory epilepsies. | BMC Neurol | 2023 | 37749503 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1457/papers?page=7